Q/C Technologies CMO granted 50,000 stock options

Q/C Technologies, Inc. reported that Chief Medical Officer Mitchell Glass received a grant of employee stock options on common stock.

Rhea-AI Filing Summary

Q/C Technologies, Inc. reported that Chief Medical Officer Mitchell Glass received a grant of employee stock options on common stock. The award covers 50,000 options, each giving the right to buy one share of common stock at an exercise price of $5.00 per share.

These options were granted on April 13, 2026 and expire on April 13, 2036. Following this grant, Glass holds 50,000 stock options directly. The options may expire earlier if he ceases to be employed by or provide services to the company.

Insider Trade Summary

Grant/Award: 50,000 shares

Grant/Award 1 txn

Insider Glass Mitchell

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy)	50,000	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (Right to Buy) — 50,000 contracts (Direct)

Footnotes (1)

1. F1. The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer.

Key Figures

Options granted: 50,000 options Exercise price: $5.00 per share Expiration date: April 13, 2036 +1 more

4 metrics

Options granted 50,000 options Employee stock option grant to CMO on April 13, 2026

Exercise price $5.00 per share Exercise price for the 50,000 stock options

Expiration date April 13, 2036 Option term end date for the grant

Post-transaction derivative holdings 50,000 options Total options held by Mitchell Glass after the grant

Key Terms

Employee Stock Option, exercise price, expiration, Common Stock

4 terms

Employee Stock Option financial

"security_title: "Employee Stock Option (Right to Buy)""

An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.

exercise price financial

"conversion_or_exercise_price: "5.0000""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration financial

"The stock options are subject to expiration if the Reporting Person ceases to be employed"

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did QCLS report for Mitchell Glass?

Q/C Technologies reported a compensation-related grant to Chief Medical Officer Mitchell Glass of 50,000 employee stock options. Each option allows him to buy one share of common stock at a $5.00 exercise price, creating a future opportunity to acquire equity rather than an immediate stock purchase.

What are the key terms of Mitchell Glass’s QCLS stock option grant?

Mitchell Glass received 50,000 employee stock options with a $5.00 exercise price per share. The options were granted on April 13, 2026 and will expire on April 13, 2036, providing a 10-year window during which he may choose to exercise them.

Did Mitchell Glass buy or sell any QCLS common stock in this filing?

No open-market buy or sell of Q/C Technologies common stock is reported. The Form 4 shows only a grant of 50,000 employee stock options, which is a compensation award. These options give future purchase rights instead of reflecting an immediate market transaction in existing shares.

How many QCLS stock options does Mitchell Glass hold after this grant?

After the reported transaction, Mitchell Glass holds 50,000 employee stock options directly. The filing shows this total as his derivative holdings following the grant, all tied to Q/C Technologies common stock with a $5.00 exercise price and a 2036 expiration date.

When do Mitchell Glass’s QCLS stock options expire and what affects them?

The options expire on April 13, 2036, giving a 10-year term from grant. A footnote explains they are subject to earlier expiration if he stops being employed by, or providing services to, Q/C Technologies, meaning continued service is a condition for keeping this award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 06:29 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glass Mitchell

(Last) (First) (Middle)

1185 AVENUE OF THE AMERICAS, SUITE 249

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Q/C TECHNOLOGIES, INC. [ QCLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$5	04/13/2026		A		50,000		04/13/2026	04/13/2036(1)	Common Stock	50,000	$0	50,000	D

Explanation of Responses:

1. The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer.

	/s/ Mitchell Glass	04/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)